Jay Lin

683 total citations
18 papers, 471 citations indexed

About

Jay Lin is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Jay Lin has authored 18 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 4 papers in Cardiology and Cardiovascular Medicine and 4 papers in Epidemiology. Recurrent topics in Jay Lin's work include Viral gastroenteritis research and epidemiology (4 papers), Hepatitis Viruses Studies and Epidemiology (4 papers) and COVID-19 Clinical Research Studies (3 papers). Jay Lin is often cited by papers focused on Viral gastroenteritis research and epidemiology (4 papers), Hepatitis Viruses Studies and Epidemiology (4 papers) and COVID-19 Clinical Research Studies (3 papers). Jay Lin collaborates with scholars based in United States, Sweden and France. Jay Lin's co-authors include Frederik Widén, Heléne Norder, Manuela Di Fusco, Jennifer L. Nguyen, Deepa Malhotra, Anita Sung, Kimberly M. Shea, Birol Emir, Jennifer Hammond and Michael Benigno and has published in prestigious journals such as Circulation, Blood and Journal of the American College of Cardiology.

In The Last Decade

Jay Lin

18 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jay Lin United States 11 285 140 64 46 45 18 471
Mahesh Patel United States 11 216 0.8× 42 0.3× 37 0.6× 91 2.0× 34 0.8× 26 442
Mohammad Alkhatib Italy 12 165 0.6× 24 0.2× 54 0.8× 57 1.2× 60 1.3× 45 408
Andrew Skingsley United Kingdom 9 355 1.2× 29 0.2× 35 0.5× 229 5.0× 49 1.1× 25 592
Fu-Meng Khaw United Kingdom 7 599 2.1× 48 0.3× 32 0.5× 113 2.5× 31 0.7× 11 863
Paola Meraviglia Italy 19 941 3.3× 111 0.8× 65 1.0× 368 8.0× 58 1.3× 61 1.3k
Caroline Korves United States 15 152 0.5× 34 0.2× 60 0.9× 63 1.4× 51 1.1× 40 541
David Ng Malaysia 11 96 0.3× 172 1.2× 41 0.6× 64 1.4× 22 0.5× 39 512
Ailing Wang China 14 116 0.4× 46 0.3× 10 0.2× 152 3.3× 32 0.7× 56 574
Mona Marin Spain 5 658 2.3× 9 0.1× 85 1.3× 114 2.5× 88 2.0× 8 1.1k
Benedikt Simon Austria 10 183 0.6× 15 0.1× 23 0.4× 127 2.8× 15 0.3× 15 336

Countries citing papers authored by Jay Lin

Since Specialization
Citations

This map shows the geographic impact of Jay Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Lin more than expected).

Fields of papers citing papers by Jay Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Lin. The network helps show where Jay Lin may publish in the future.

Co-authorship network of co-authors of Jay Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Jay Lin. A scholar is included among the top collaborators of Jay Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay Lin. Jay Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Xing, Fa, et al.. (2023). Substrate Copper Trace Crack Characterization and Simulation. 699–705. 7 indexed citations
2.
Fusco, Manuela Di, Jay Lin, Melissa Lingohr-Smith, et al.. (2022). COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies. Expert Review of Vaccines. 21(4). 435–451. 47 indexed citations
3.
Fusco, Manuela Di, Mary M. Moran, Jay Lin, et al.. (2022). COVID-19-associated hospitalizations among children less than 12 years of age in the United States. Journal of Medical Economics. 25(1). 334–346. 13 indexed citations
4.
Fusco, Manuela Di, Kimberly M. Shea, Jay Lin, et al.. (2021). Health outcomes and economic burden of hospitalized COVID-19 patients in the United States. Journal of Medical Economics. 24(1). 308–317. 135 indexed citations
5.
Baker, Christine L., Amol D. Dhamane, Jack Mardekian, et al.. (2019). Abstract 210: Rates of Drug Switching and Discontinuation among Nonvalvular Atrial Fibrillation Elderly Patients Treated with Direct Oral Anticoagulants in the US. Circulation Cardiovascular Quality and Outcomes. 12(Suppl_1). 1 indexed citations
6.
Wen, Lonnie, et al.. (2018). Improving quality of care in oncology through healthcare payment reform.. PubMed. 24(3). e93–e98. 10 indexed citations
7.
Deitelzweig, Steve, Xuemei Luo, Kiran Gupta, et al.. (2016). Abstract 17298: Real-world Evaluation of Healthcare Resource Use and Costs of Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Apixaban vs. Warfarin in the US. Circulation. 134. 1 indexed citations
9.
Lin, Jay, Lars O. Magnius, Marie Karlsson, et al.. (2016). Markers for Ongoing or Previous Hepatitis E Virus Infection Are as Common in Wild Ungulates as in Humans in Sweden. Viruses. 8(9). 259–259. 33 indexed citations
10.
Deitelzweig, Steven, Michael A. Evans, Eric Hillson, et al.. (2015). DOES WARFARIN TIME-IN-THERAPEUTIC RANGE AFFECT HEALTHCARE RESOURCE UTILIZATION AND COSTS AMONG NONVALVULAR ATRIAL FIBRILLATION PATIENTS IN THE U.S.?. Journal of the American College of Cardiology. 65(10). A1515–A1515. 1 indexed citations
11.
Lin, Jay, Marie Karlsson, Sándór Belák, et al.. (2015). High Prevalence of Hepatitis E Virus in Swedish Moose – A Phylogenetic Characterization and Comparison of the Virus from Different Regions. PLoS ONE. 10(4). e0122102–e0122102. 31 indexed citations
13.
Levin, Philip, Wenhui Wei, Aleksandra Vlajnic, et al.. (2014). Initiating Injectable Therapy in US Managed Care Patients With Diabetes. The American Journal of Managed Care. 6. 1 indexed citations
14.
Widén, Frederik, et al.. (2014). PCR detection and analyzis of potentially zoonotic Hepatitis E virus in French rats. Virology Journal. 11(1). 90–90. 30 indexed citations
15.
Lin, Jay, Heléne Norder, Henrik Uhlhorn, Sándor Bélak, & Frederik Widén. (2013). Novel hepatitis E like virus found in Swedish moose. Journal of General Virology. 95(3). 557–570. 51 indexed citations
16.
Topalis, Dimitri, Ugo Pradère, Vincent Roy, et al.. (2010). Novel Antiviral C5-Substituted Pyrimidine Acyclic Nucleoside Phosphonates Selected as Human Thymidylate Kinase Substrates. Journal of Medicinal Chemistry. 54(1). 222–232. 45 indexed citations
17.
Lin, Jay, Vincent Roy, Liya Wang, et al.. (2010). 3′-(1,2,3-Triazol-1-yl)-3′-deoxythymidine analogs as substrates for human and Ureaplasma parvum thymidine kinase for structure–activity investigations. Bioorganic & Medicinal Chemistry. 18(9). 3261–3269. 20 indexed citations
18.
Amin, Alpesh, Stephen Stemkowski, Jay Lin, & Guiping Yang. (2008). Appropriate thromboprophylaxis in hospitalized cancer patients.. PubMed. 6(12). 910–20. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026